Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

News > All

Total search results: 3979 | Ordered by Date (descending)
1 2 3 ... 38 39 40  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immunic AG. (12/12/17). "Press Release: Immunic Therapeutics Successfully Completes Two Phase 1 Studies for IMU-838". Planegg-Martinsried. 2017-12-12
NorthSea Therapeutics B.V.. (12/12/17). "Press Release: NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug". Naarden. 2017-12-12
Adrenomed AG. (12/11/17). "Press Release: Adrenomed AG Doses First Patient in Proof of Concept Study with Adrecizumab to Treat Patients with Early Septic Shock". Hennigsdorf. 2017-12-11
Hookipa Biotech AG. (12/11/17). "Press Release: Hookipa Biotech Raises $60 Million (€50 Million) in an Oversubscribed Round C Financing". Vienna. 2017-12-11
Idex Corporation. (12/11/17). "Press Release: Idex Corporation to Acquire thinXXS Microtechnology AG". Lake Forest, IL. 2017-12-11
CRISPR Therapeutics AG. (12/10/17). "Press Release: CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for ß-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting". Zug & Cambridge, MA. 2017-12-10
bio.logis Genetic Information Management GmbH. (12/8/17). "Press Release: bio.logis GIM GmbH Concludes a Distribution Agreement with PGS.Holland BV". 2017-12-08
Qiagen N.V.. (12/8/17). "Press Release: Qiagen to Transfer U.S. Listing of Global Shares to NYSE". Germantown, MD & Hilden. 2017-12-08
CRISPR Therapeutics AG. (12/7/17). "Press Release: CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in ß-thalassemia". Zug & Cambridge, MA. 2017-12-07
Cell Medica Ltd.. (12/7/17). "Press Release: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair". 2017-12-07
Coulter Partners. (12/7/17). "Press Release: Coulter Partners Helps Secure Industry Leader, Dr Annalisa Jenkins as Chair for Cell Medica". 2017-12-07
Novartis AG. (12/7/17). "Press Release: Novartis Tender Offer for Advanced Accelerator Applications Commences". Basel. 2017-12-07
Pieris Pharmaceuticals, Inc.. (12/7/17). "Press Release: Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402". Boston, MA. 2017-12-07
ERS Genomics Ltd.. (12/6/17). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Charles River". Dublin. 2017-12-06
BGI. (12/6/17). "Press Release: BGI and Hummingbird Diagnostics Sign Memorandum of Understanding". Shenzhen & Heidelberg. 2017-12-06
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
Paion AG. (12/6/17). "Press Release: Jürgen Beck, MD, Appointed as Chief Development Officer at Paion AG". Aachen. 2017-12-06
Proteros Biostructures GmbH. (12/6/17). "Press Release: Proteros Names Dave Lemus as New Executive Board Member". Munich. 2017-12-06
Probiodrug AG. (12/5/17). "Press Release: Probiodrug and Crossbeta Biosciences Extend Their Strategic Partnership in the Field of Alzheimer’s Disease Biomarkers". Halle (Saale) & Utrecht. 2017-12-05
Medigene AG. (12/5/17). "Press Release: Medigene Sells US-rights for Veregen and Raises Financial Guidance 2017". Martinsried. 2017-12-05
ERS Genomics Ltd.. (12/5/17). "Press Release: Horizon Extends Industry-Leading Gene Editing IP Portfolio through Expansion of CRISPR License Rights with ERS Genomics". Dublin & Cambridge. 2017-12-05
Idorsia Ltd.. (12/4/17). "Press Release: Idorsia Announces Collaboration with Janssen Biotech on Aprocitentan (ACT-132577)". Allschwil. 2017-12-04
Sanofi S.A.. (12/4/17). "Press Release: Sanofi’s Toujeo Met Main Objective in Head-to-head Study versus Insulin Degludec". Paris. 2017-12-04
Ncardia. (12/4/17). "Press Release: Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells". Gosselies. 2017-12-04
Sanofi S.A.. (12/1/17). "Press Release: Sanofi Ends Development of Clostridium Difficile Vaccine". Paris. 2017-12-01
Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel. 2017-12-01
Evotec AG. (12/1/17). "Press Release: Evotec Receives Clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2017-12-01
Bayer AG. (12/1/17). "Press Release: CFIUS Completes Review of Proposed Merger of Bayer and Monsanto". Leverkusen & St. Louis, MI. 2017-12-01
Agena Bioscience, Inc.. (11/30/17). "Press Release: Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union". San Diego, CA. 2017-11-30
MorphoSys AG. (11/30/17). "Press Release: MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab". Planegg. 2017-11-30
Probiodrug AG. (11/30/17). "Press Release: Probiodrug Reports Third Quarter 2017 Business Update". Halle (Saale). 2017-11-30
Bayer AG. (11/30/17). "Press Release: Bayer Combines Pharmaceutical Research and Development Unit [Not intended for U.S. and UK Media]". Leverkusen. 2017-11-30
Bayer AG. (11/30/17). "Press Release: Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate and Prednisone/Prednisolone for Patients with Metastatic Castration-resistant Prostate Cancer Unblinded Early [Not intended for U.S. an 2017-11-30
Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". 2017-11-30
Sanofi S.A.. (11/29/17). "Press Release: Sanofi Updates Information on Dengue Vaccine. New Analysis of Long-term Dengvaxia Data Found Differences in Vaccine Performance Based on Prior Dengue Infection". Paris. 2017-11-29
Epigenomics AG. (11/29/17). "Press Release: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand)". Berlin & Germantown, MD. 2017-11-29
Bluebird Bio, Inc.. (11/29/17). "Press Release: Bluebird Bio Acquires Manufacturing Facility in North Carolina and Executes Multiple Global Supply Agreements to Enhance Ability to Deliver Gene Therapies to Patients". Cambridge, MA. 2017-11-29
Genedata AG. (11/28/17). "Press Release: New Release of Genedata Selector Revolutionizes Genomic Data Management and Analysis for Key Biopharma Applications". Basel. 2017-11-28
iOnctura S.A.. (11/28/17). "Press Release: iOnctura Announces Appointment of Leading International Scientific Advisory Board". Geneva. 2017-11-28
Sphere Fluidics Ltd.. (11/27/17). "Press Release: Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant". Cambridge & Geneva. 2017-11-27
Medigene AG. (11/27/17). "Press Release: Patient Recruitment Completed for Phase I/II DC Vaccine Trial in AML". Planegg. 2017-11-27
BioMed X GmbH. (11/27/17). "Press Release: BioMed X and Boehringer Ingelheim Start New Joint Research Group in Bacterial Modulation of Innate Immunity". Heidelberg. 2017-11-27
Analytik Jena AG. (11/27/17). "Press Release: Analytik Jena and BAM Agree to Cooperate in Research". Jena. 2017-11-27
Bayer AG. (11/27/17). "Press Release: Bayer Is Expanding Its Collaboration with Bitkom". Leverkusen & Berlin. 2017-11-27
Biocartis Group N.V.. (11/27/17). "Press Release: Biocartis Launches CE-marked IVD RAS Liquid Biopsy Tests Developed under Partnership with Merck KGaA, Darmstadt, Germany". Mechelen. 2017-11-27
MorphoSys AG. (11/23/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis". Planegg. 2017-11-23
Royal Philips. (11/23/17). "Press Release: Philips-led Research Consortium Awarded EUR 6.3 Million EU Grant to Develop Integrated Approaches for Personalized Cancer Treatment". Amsterdam. 2017-11-23
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Boehringer Ingelheim. (11/20/17). "Press Release: Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community via opnMe.com to Unlock Their Full Potential". Ingelheim. 2017-11-20
Jennewein Biotechnologie GmbH. (11/20/17). "Press Release: EU Approval for 2'-fucosyllactose". 2017-11-20
Roche. (11/17/17). "Press Release: FDA Approves Roche’s Gazyva for Previously Untreated Advanced Follicular Lymphoma". Basel. 2017-11-17
Roche. (11/17/17). "Press Release: Roche to Acquire Viewics, Inc. to Provide Data-driven Lab Business Analytics and Add further Digital Capabilities along the Laboratory Value Chain". Basel. 2017-11-17
Ncardia. (11/17/17). "Press Release: Ncardia Announces Completion of €10.5m Investment Round". Gosselies. 2017-11-17
Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich. 2017-11-16
Goodwin Procter LLC. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock". 2017-11-16
High-Tech Gründerfonds Management GmbH. (11/16/17). "Press Release: EWE Invests in High-Tech Gründerfonds III". 2017-11-16
Molecular Health GmbH. (11/16/17). "Press Release: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction". Cambridge, MA. 2017-11-16
Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. 2017-11-16
Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen. 2017-11-16
bio.logis Genetic Information Management GmbH. (11/16/17). "Press Release: Laboratory Group Laboratoires Réunis Capitalizes Genetic Information Management Software Suite for Complex Laboratory Reports". 2017-11-16
Curetis N.V.. (11/16/17). "Press Release: Curetis Publishes Business and Financial Update for the First Nine Months of 2017". Amsterdam & Holzgerlingen. 2017-11-16
Roche. (11/16/17). "Press Release: FDA Approves Roche’s Hemlibra (emicizumab-kxwh) for Haemophilia A with Inhibitors". Basel. 2017-11-16
Boehringer Ingelheim. (11/15/17). "Press Release: Key Sub-analyses of RE-DUAL PCI Showed Large Reductions in the Incidence of Bleeding Complications if Pradaxa (dabigatran etexilate) Dual Therapy Was Used Instead of Warfarin Triple Therapy". Ingelheim. 2017-11-15
Arvinas, LLC. (11/15/17). "Press Release: Arvinas Expands Strategic License Agreement with Genentech". New Haven, CT. 2017-11-15
High-Tech Gründerfonds Management GmbH. (11/14/17). "Press Release: Scipio Bioscience Announces Its Seed Funding". 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: Jardiance Reduced Risk of Cardiovascular Death in Adults with Type 2 Diabetes and Peripheral Artery Disease". Ingelheim & Indianapolis, IN. 2017-11-14
Boehringer Ingelheim. (11/14/17). "Press Release: New RE-VERSE AD Analyses Provide Additional Insights on Impact of Praxbind (idarucizumab) in Pradaxa (dabigatran etexilate) Patients with Gastrointestinal Bleeding or Needing Emergency Surgery". Ingelheim 2017-11-14
Loxo Oncology, Inc.. (11/14/17). "Press Release: Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195". Stamford, CT. 2017-11-14
Qiagen N.V.. (11/14/17). "Press Release: Qiagen’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology". Hilden & Germantown, MD. 2017-11-14
Definiens AG. (11/13/17). "Press Release: Definiens Strengthens Position as Global Service Provider in Biopharma. Jacques Corriveau Joining as General Manager North America". Munich. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs". Zug, Cambridge, MA, Tübingen & Boston, MA. 2017-11-13
Boehringer Ingelheim. (11/13/17). "Press Release: Cyltezo, Adalimumab Biosimilar from Boehringer Ingelheim, Approved in Europe for the Treatment of Multiple Chronic Inflammatory Diseases". Ingelheim. 2017-11-13
CRISPR Therapeutics AG. (11/13/17). "Press Release: CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer". Zug & Cambridge, MA. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic [The information contained in this release is not appropriate for audiences in the USA and Canada]". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Introduces Stericup Quick Release System for Improved Cell Culture Filtration". Darmstadt. 2017-11-13
Merck KGaA. (11/13/17). "Press Release: Merck Receives FDA Approval for New Gonal-f Prefilled Pen [Not intended for U.S. and UK based media]". Darmstadt. 2017-11-13
Royal Philips. (11/13/17). "Press Release: German Armed Forces to Use Customized Philips Lumify Ultrasound for Its Emergency and Rescue Operations". Amsterdam. 2017-11-13
Qiagen N.V.. (11/13/17). "Press Release: Qiagen Celebrates Surpassing 2,000 Cumulative Placements of QIAsymphony". Hilden & Germantown, MD. 2017-11-13
Affimed N.V.. (12/11/17). "Press Release: Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH". Heidelberg. 2017-11-12
Boehringer Ingelheim. (11/10/17). "Press Release: Boehringer Ingelheim Presents New Data for Pradaxa and Its Specific Reversal Agent Praxbind at AHA Scientific Sessions 2017". Ingelheim. 2017-11-10
DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia. 2017-11-09
Vetter Pharma International GmbH. (11/9/17). "Press Release: Vetter Expands Its Footprint in Asia Pacific Region. Company Establishes Its Presence in South Korea". Songdo & Ravensburg. 2017-11-09
Valneva S.E.. (11/9/17). "Press Release: Valneva Reports Strong Operational Performance for the First Nine Months of 2017". Lyon. 2017-11-09
InflaRx N.V.. (11/8/17). "Press Release: InflaRx Announces Pricing of Initial Public Offering". Jena. 2017-11-08
Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London. 2017-11-08
Definiens AG. (11/8/17). "Press Release: Definiens Broadens Immuno-Oncology Service Offer. Predictive Multi-biomarkers for Accelerated Immuno-oncological Progress". Washington, D.C.. 2017-11-08
Evotec AG. (11/8/17). "Press Release: Evotec AG Announces First Nine-month 2017 Results and Corporate Update". Hamburg. 2017-11-08
CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA. 2017-11-08
MorphoSys AG. (11/7/17). "Press Release: MorphoSys Announces Third Quarter 2017 Results". Planegg. 2017-11-07
Compugen Ltd.. (11/7/17). "Press Release: Compugen Reports Third Quarter 2017 Results". Holon. 2017-11-07
Valneva S.E.. (11/7/17). "Press Release: Valneva Signs $39.6 Million Ixiaro Supply Contract with US Government". Lyon. 2017-11-07
NousCom AG. (11/6/17). "Press Release: NousCom Raises €42 Million Series B Financing". Basel. 2017-11-06
Boehringer Ingelheim. (11/6/17). "Press Release: Efficacy and Safety Maintained in Patients Who Switched from Humira to Biosimilar Cyltezo". Ingelheim. 2017-11-06
Compugen Ltd.. (11/6/17). "Press Release: Compugen to Initiate Manufacturing of COM902, Its Lead antiTIGIT Monoclonal Antibody". Holon. 2017-11-06
Eurofins Scientific. (11/6/17). "Press Release: Eurofins Successfully Prices EUR 400m New Hybrid Bond". 2017-11-06
Evotec AG. (11/6/17). "Press Release: Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build »NEPLEX«". Hamburg. 2017-11-06
Qiagen N.V.. (11/6/17). "Press Release: Qiagen Reports Results for Third Quarter and First Nine Months of 2017". Venlo. 2017-11-06
Glycotope GmbH. (11/3/17). "Press Release: Celonic Acquires Glycotope’s Biomanufacturing Facility". Basel. 2017-11-03
Boehringer Ingelheim. (11/2/17). "Press Release: Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)". Ingelheim & Cambridge, MA. 2017-11-02
Topas Therapeutics GmbH. (11/2/17). "Press Release: Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund". Hamburg. 2017-11-02
1 2 3 ... 38 39 40  next pagenext page



Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px